ARCHIVES

Revlimid Also Demonstrates Response in Mantle Cell

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

Komen Foundation Awards New Grants

October 20, 1995

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988